Aristo Bio-Tech And Lifescience Limited announced financial results for the year ending March 31, 2025, along with a final dividend recommendation of Rs. 0.50 per equity share, and management changes with the resignation of Company Secretary Ayushi Deora and the appointment of Diksha Jaiprakash Peswani effective May 29, 2025.